Covid19

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting
  • SARS-CoV Infection
  • Covid19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +5 more
  • Birmingham, Alabama
  • +155 more
Dec 16, 2022

Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Tucson, Arizona
  • +39 more
Dec 16, 2022

Blood Purification With Seraph 100 Microbind Affinity Blood

Active, not recruiting
  • Covid19
  • Observational
  • Los Angeles, California
  • +13 more
Oct 31, 2022

Covid19 Trial in United States (IFN beta-1a, Dexamethasone)

Terminated
  • Covid19
  • Aurora, Colorado
  • +3 more
Oct 13, 2022

Covid19, SARS-CoV Infection Trial in United States (Metformin, Placebo, Fluvoxamine)

Active, not recruiting
  • Covid19
  • SARS-CoV Infection
  • Sylmar, California
  • +6 more
Aug 5, 2022

Covid19 Trial in Argentina, Brazil, United States (rNAPc2, Heparin)

Completed
  • Covid19
  • Fairhope, Alabama
  • +23 more
May 25, 2022

Covid19 Trial in United States (Convalescent Plasma, Saline)

Completed
  • Covid19
  • Convalescent Plasma
  • Saline
  • Chandler, Arizona
  • +52 more
Oct 15, 2021

Following Treatment With COVID19 Convalescent Plasma in

Completed
  • Covid19
    • Aurora, Colorado
    • +5 more
    Jun 8, 2021

    Acute and Chronic Kidney Disease Incidence and Outcomes in

    Enrolling by invitation
    • Covid19
    • +4 more
      • Birmingham, Alabama
      • +11 more
      Jul 27, 2020